Thus, a therapeutic strategy for amyotrophic lateral sclerosis based on inhibition of exosomes production based on in vivo data that suggest that exosomes secretion plays an overall beneficial role in neuronal clearance of pathological TDP-43 would be inadvisable (Iguchi et al., 2016). The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.